Status:
COMPLETED
ARIA to Predict Coronary Artery Disease in HIV-infected Individuals
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Hiv
Coronary Artery Disease
Eligibility:
All Genders
30+ years
Brief Summary
With effective anti-retroviral therapy, non-communicable diseases, such as cardiovascular diseases, have become the major cause of morbidity and mortality for people living with HIV. There is only lim...
Eligibility Criteria
Inclusion
- Positive anti-HIV antibody
- Age 30 or above
- Presence of one or more risk factors for cardiovascular disease
Exclusion
- Presence of overt coronary artery disease
- Impaired renal function
- Allergy to intravenous contrast
- Pregnancy
Key Trial Info
Start Date :
May 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03874221
Start Date
May 7 2019
End Date
March 31 2023
Last Update
September 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Shatin, Hong Kong